Human resource development contributes to the creation of outstanding regenerative medicine products

被引：5

作者：

Nishigaki, Fusako ^{[1
,2
]}

Ezoe, Sachikon ^{[3
]}

Kitajima, Hideki ^{[3
]}

Hata, Kenichiro ^{[2
,4
]}

机构：

[1] Astellas Pharma Inc, Regenerat Med Labs, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan

[2] FIRM, Chuo Ku, 2-3-11 Nihonbashi Honcho, Tokyo 1030023, Japan

[3] Osaka Univ Hosp, Dept Med Innovat, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan

[4] Japan Tissue Engn Co Ltd J TEC, Gamagori, Aichi, Japan

来源：

REGENERATIVE THERAPY | 2017年 / 7卷

关键词：

Regenerative medicine; Human resource; Education; Training; JAPAN; GENE;

D O I：

10.1016/j.reth.2017.06.002

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Regenerative medicine is currently the focus of global attention. Countries all around the world are actively working to create new regenerative treatment modalities through pioneering research and novel technologies. This is wonderful news for patients who could not be treated with existing medical options. New venture businesses and companies are being established in regenerative medicine and their rapid industrialization is anticipated. However, to ensure high-quality products, human resources qualified in research and development and the manufacturing of these products are essential. The Forum for Innovative Regenerative Medicine (FIRM) conducted a questionnaire of its industry members to examine the training and hiring of people in research and development, product creation, manufacturing, and more. Regenerative medicine is a brand new field; thus, many different businesses will need to cooperate together. People with a broad range of technical skills, abilities, and knowledge will be in demand, with various levels of expertise, from basic to advanced. (C) 2017, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.

引用

页码：17 / 23

页数：7

共 50 条

[1] Regulation of Regenerative Medicine Products
Gee, Adrian P.
CARDIAC EXTRACELLULAR MATRIX: FUNDAMENTAL SCIENCE TO CLINICAL APPLICATIONS, 2018, 1098 : 189 - 198
[2] Development of a student-driven undergraduate program in regenerative medicine
Sandoval, Aaron Gabriel W.
Traktuev, Dmitry O.
March, Keith L.
REGENERATIVE MEDICINE, 2022, 17 (10) : 755 - 765
[3] Achieving reimbursement for regenerative medicine products in the USA
Ginty, P. J.
Singh, P. B.
Smith, D.
Hourd, P.
Williams, D. J.
REGENERATIVE MEDICINE, 2010, 5 (03) : 463 - 469
[4] The Role of Preservation in the Variability of Regenerative Medicine Products
Yu, Guanglin
Hubel, Allison
REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE, 2019, 5 (04) : 323 - 331
[5] The Role of Preservation in the Variability of Regenerative Medicine Products
Guanglin Yu
Allison Hubel
Regenerative Engineering and Translational Medicine, 2019, 5 : 323 - 331
[6] Regenerative medicine: applications and development in urology
Pinto, F.
Calarco, A.
Brescia, A.
Sacco, E.
D'Addessi, A.
Racioppi, M.
Bassi, P. F.
UROLOGIA JOURNAL, 2007, 74 (04) : 197 - 205
[7] Stem/progenitor cells in the cerebral cortex of the human preterm: a resource for an endogenous regenerative neuronal medicine?
Vinci, Laura
Ravarino, Alberto
Gerosa, Clara
Pintus, Maria Cristina
Marcialis, Maria Antonietta
Marinelli, Viviana
Faa, Gavino
Fanos, Vassilios
Ambu, Rossano
JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE, 2016, 5 (01):
[8] Overview of the clinical application of regenerative medicine products in Japan
Tsubouchi, Mina
Matsui, Shigeyuki
Banno, Yoshiro
Kurokawa, Kiyoshi
Kawakami, Koji
HEALTH POLICY, 2008, 88 (01) : 62 - 72
[9] The politics of valuation and payment for regenerative medicine products in the UK
Faulkner, Alex
Mahalatchimy, Aurelie
NEW GENETICS AND SOCIETY, 2018, 37 (03) : 227 - 247
[10] d-Glucosamine contributes to cell membrane stability and regenerative medicine
Yoshihiko Hayashi
Environmental Chemistry Letters, 2020, 18 : 75 - 77

← 1 2 3 4 5 →